Robert J. Chorvat

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Joseph Tam, Jie Liu, Grzegorz Godlewski et al. · Cell Metabolism · 2012 · 342 citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +11

Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine

Robert Zaczek, Robert J. Chorvat, J Saye et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 130 citations

JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities

Robert J. Chorvat, Jennifer Berbaum, Kristine Seriacki et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 88 citations · Full text

Cns Liabilities, Cannabis Use, Functional Selectivity +8

Non-Peptide Corticotropin-Releasing Hormone Antagonists:  Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines

Argyrios G. Arvanitis, Paul J. Gilligan, Robert J. Chorvat et al. · Journal of Medicinal Chemistry · 1999 · 74 citations · Full text

Inhibition of cholesteryl ester formation in human fibroblasts by an analogue of 7-ketocholesterol and by progesterone

Joseph L. Goldstein, Jerry R. Faust, John H. Dygos et al. · Proceedings of the National Academy of Sciences · 1978 · 71 citations · Full text